SIRT2 and posterior cortical atrophy: These findings underscore SIRT2’s critical involvement in both the epigenetic modulation of oncogenic pathways and the metabolic adaptation of PCa, positioning it as a promising target for therapeutic intervention in advanced and treatment-resistant forms of the disease.